IPO Issue Details
Issue Price / Price Band₹42 per share (Fixed Price)
Face Value₹10 Per Share
Lot Size3,000 Shares per Lot
Total Issue Size38,16,000 shares (aggregating up to ₹16.03 Cr)
Issue TypeFixed Price IPO
Sale Type / CategoryFresh Capital
Exchange / PlatformBSE SME
IPO TypeSME
Subscription OpenThu, 10 Aug 2023
Subscription CloseMon, 14 Aug 2023
Anchor AllotmentWed, 09 Aug 2023
Basis of AllotmentFri, 18 Aug 2023
Initiation of RefundsMon, 21 Aug 2023
Credit of Shares to DematTue, 22 Aug 2023
Listing DateWed, 23 Aug 2023
UPI Mandate Deadline2023-08-14
Application & Investment Details
Retail — Min (1 Lots)₹1,26,000 — 3,000 shares
Retail — Max (13 Lots)₹1,638,000 (13 Lots)
HNI — Min (2 Lots)₹2,52,000 — 6,000 shares
EPS (Pre-IPO)₹7.47
P/E Ratio (Pre-IPO)5.62x
Net Offer to Public36,24,000 shares (aggregating up to ₹15.22 Cr)
Reserved for Market Maker1,92,000 shares (aggregating up to ₹0.8064 Cr)
Pre-IPO Promoter Holding77,43,792 shares
Post-IPO Promoter Holding1,15,59,792 shares
About https://ipo.bigshareonline.com/IPO_Status.htmlShelter Pharma Ltd.
Incorporated in 2007, Shelter Pharma Limited, previously known as Shelter Pharmacy, is engaged in the business of manufacturing herbal products in Human Pharma as well as the Veterinary space.The company manufactures herbal medicines that cover veterinary, poultry, and human health care. Headquartered in Himmatnagar, Gujarat, the aim of the company is to offer cost-effective and superior solutions to the health problems of humans and animals.There is a comprehensive range of health supplements offered by the company for the betterment of humans and poultry. Ayurveda meets modernity - This is the driving force behind the company.Shelter Pharma's product list includes Human Healthcare products such as Lemonade Barley Water, Sherolax, Baldeepak, and Stonyl Tablets and Veterinary Healthcare products such as Agrical Powder, Lactocal gel, Shelodex Ultra Ointment.Shelter clientele comes from rural/semi-urban markets.
Objects of the Issue
https://ipo.bigshareonline.com/IPO_Status.htmlShelter Pharma Ltd. proposes to utilise the net proceeds from the Issue for the following objects:
1
Working Capital Requirements
14.00
2
General Corporate Purposes
0.88
Shareholding & Lock-in
Pre-IPO Promoter Holding
77,43,792 shares
Post-IPO Promoter Holding
1,15,59,792 shares